These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36331957)

  • 1. Ultrasononography in Managing Extrapulmonary Tuberculosis: A Randomized, Controlled, Parallel, Superiority, Open-Label Trial.
    Ndege R; Ngome O; Vanobberghen F; Bani F; Temba Y; Wilson H; Hella J; Gingo W; Sasamalo M; Mnzava D; Kimera N; Hiza H; Wigayi J; Mapesi H; Kato IB; Mhimbira F; Reither K; Battegay M; Paris DH; Weisser M; Rohacek M
    Clin Infect Dis; 2023 Mar; 76(6):1013-1021. PubMed ID: 36331957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study.
    Ndege R; Ngome O; Bani F; Temba Y; Wilson H; Vanobberghen F; Hella J; Gingo W; Sasamalo M; Mnzava D; Kimera N; Hiza H; Wigayi J; Mapesi H; Kato IB; Mhimbira F; Reither K; Battegay M; Paris DH; Weisser M; Rohacek M
    BMC Infect Dis; 2020 May; 20(1):349. PubMed ID: 32414338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
    Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
    Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.
    Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonography to Rule Out Tuberculosis in Sub-Saharan Africa: A Prospective Observational Study.
    Ndege R; Weisser M; Elzi L; Diggelmann F; Bani F; Gingo W; Sikalengo G; Mapesi H; Mchomvu E; Kamwela L; Mnzava D; Battegay M; Reither K; Paris DH; Rohacek M
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz154. PubMed ID: 31041350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
    Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Gupta-Wright A; Corbett EL; van Oosterhout JJ; Wilson D; Grint D; Alufandika-Moyo M; Peters JA; Chiume L; Flach C; Lawn SD; Fielding K
    Lancet; 2018 Jul; 392(10144):292-301. PubMed ID: 30032978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.
    Gupta-Wright A; Fielding KL; van Oosterhout JJ; Wilson DK; Corbett EL; Flach C; Reddy KP; Walensky RP; Peters JA; Alufandika-Moyo M; Lawn SD
    BMC Infect Dis; 2016 Sep; 16(1):501. PubMed ID: 27659507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
    Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
    Kay AW; Ness T; Verkuijl SE; Viney K; Brands A; Masini T; González Fernández L; Eisenhut M; Detjen AK; Mandalakas AM; Steingart KR; Takwoingi Y
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013359. PubMed ID: 36065889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.